New collaboration will enhance ability to identify those more at risk of developing brain diseases to enable earlier interventions.
From PharmaKureFeb 29 2024Reviewed by Lily Ramsey, LLM PharmaKure, a clinical stage pharmaceutical company developing precision medicines for Alzheimer’s Disease and other neurodegenerative diseases, today announces a new epigenetics collaboration with Sheffield Hallam University. This partnership will focus on ‘gene-based environmental biomarkers,’ known as epigenetic markers, for calculating risk scores for Alzheimer’s disease.
“We have been working on the relationship of environmental stresses with respect to brain diseases.” Professor Reynolds has published over 300 papers on the pathology of neurotransmitter systems involved in psychiatric disorders and now focuses on epigenetics effects in neurodiseases.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Sheffield business fined due to condition of staff toiletBrightside Motors is ordered to pay more than £10,000 after failing to provide clean facilities.
続きを読む »
Premier League: Wolves see off Sheffield United to move eighthListen to 5 Live commentary and follow live text as Wolves beat Sheffield United in the Premier League.
続きを読む »
Japan Day celebrated at Preston’s university for 10th yearEvent organiser Chisa takes to the catwalk wearing the traditional Japanese kimono. Pic: UCLan The University of Central Lancashire (UCLan) hosted its annua
続きを読む »
Glasgow University students' anger over reintroduction of in-person examsGlasgow University says the return to closed-book exams follows concern about artificial intelligence.
続きを読む »
Reading University granted permission for weather centre headquartersNew European Centre for medium-range weather forecasts headquarters at the University are approved
続きを読む »
Is running a top university America’s hardest job?Balancing a motley crew of interested parties is becoming nearly impossible
続きを読む »